Telegraph coverage
As you may have seen, our exclusive press briefing with Bupa, which unveiled a pilot genomic screening service and their plans for targeted health prevention have make the headlines.
Click here to read Michael Searle’s piece in the Telegraph. And here for coverage in The Times. If you weren’t able to join the webinar, catch up with the recording in the members’ only section on Resources.
We hope this will be the first of many exclusive briefings for MJA members, so keep an eye on the website for updates. And if you’re not already a member — it’s yet another reason to join the UK’s largest membership organisation for health and medical journalists. Check your eligibility to join and details here.
OPERATIONAL NOTICE – STRICTLY NOT FOR REPORTING
The MJA is hosting an exclusive press briefing for MJA members on news that Bupa is planning to launch a new genomic screening service in the UK.
This will be held on Monday 14 October 2024, from 10.30am to 11.30am. To receive an invitation to this virtual briefing, you must register via the form below.
Following a successful trial, whole genomic sequencing will be made available to Bupa customers. Bupa currently has 3.8 million insured UK customers.
The virtual briefing will describe how the new service will test for 35 diseases, including 16 different cancers. It will also explore what this new development means for customer insurance.
Patients opting for the tests will receive a personalised guide to understanding their genetic risk profile of developing actionable diseases in five clinical areas, including cancer, heart health, metabolic disease, carrier gene status and pharmacogenomics.
An embargoed press release will be sent to all journalists who register for the briefing.
The media briefing will be delivered by:
- Dr Rishi Patel, Head of Clinical Transformation at Bupa – Bupa’s clinical head for the genomics programme
- Sarah Melia, General Manager for Bupa Health Services, – Bupa’s operational lead for the genomics programme
- Nicola Green, Bupa’s Commercial Director – Bupa’s insurance lead for the programme
The panel will answer questions on:
- How the programme will work and what patients can expect to learn about their health
- Bupa’s plans to support patients at risk of different diseases
- What this sort of innovation could mean for the broader health and care landscape in the UK
The virtual briefing will be held on Monday 14 October 2024 from 10.30am to 11.30am. To register for the briefing please complete the form below.
The press release and content of the media briefing will be under strict embargo until 00.01 on Wednesday 16 October 2024.
Recent Comments